Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Maternal Short Course of Tenofovir Disoproxil Fumarate and Infant Vaccine to Prevent Mother-to-child Transmission of Hepatitis B Virus

NCT03343431 is registered in ClinicalTrials.gov with Institut de Recherche pour le Developpement as lead sponsor.

NCT NCT03343431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03343431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Maternal Short Course of Tenofovir Disoproxil Fumarate and Infant Vaccine to Prevent Mother-to-child Transmission of Hepatitis B Virus
Lead sponsor
Institut de Recherche pour le Developpement
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 2, 2018
Completion date
June 30, 2025
Enrollment
504 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, pregnancy